Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Johnson

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Pediatrics|July 1, 1995
Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndromeG S Tint, G Salen, A K Batta, et al.
American Journal of Medical Genetics|January 31, 1997
Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trialM Irons, E R Elias, D Abuelo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7 and evidence for genetic heterogeneityM Muenke, F Gurrieri, C Bay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I studyG L Phillips, B Meisenberg, D E Reece, et al.
Bone Marrow Transplantation|February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphomaG L Phillips, B R Meisenberg, D E Reece, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Pediatrics|July 1, 1995
Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndromeG S Tint, G Salen, A K Batta, et al.
American Journal of Medical Genetics|January 31, 1997
Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trialM Irons, E R Elias, D Abuelo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7 and evidence for genetic heterogeneityM Muenke, F Gurrieri, C Bay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I studyG L Phillips, B Meisenberg, D E Reece, et al.
Bone Marrow Transplantation|February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphomaG L Phillips, B R Meisenberg, D E Reece, et al.
Pageof 5